Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.

Weisdorf D, Cooley S, Wang T, Trachtenberg E, Vierra-Green C, Spellman S, Sees JA, Spahn A, Vogel J, Fehniger TA, Woolfrey AE, Devine SM, Ross M, Waller EK, Sobecks RM, McGuirk J, Oran B, Farag SS, Shore T, Van Besien K, Marsh SGE, Guethlein LA, Parham P, Miller JS.

Blood Adv. 2020 Feb 25;4(4):740-754. doi: 10.1182/bloodadvances.2019001053.

2.

Medication management abilities are reduced in older persons living with HIV compared with healthy older HIV- controls.

Cooley SA, Paul RH, Ances BM.

J Neurovirol. 2020 Jan 27. doi: 10.1007/s13365-020-00827-2. [Epub ahead of print]

PMID:
31989445
3.

Potential socioeconomic impacts from ocean acidification and climate change effects on Atlantic Canadian fisheries.

Wilson TJB, Cooley SR, Tai TC, Cheung WWL, Tyedmers PH.

PLoS One. 2020 Jan 10;15(1):e0226544. doi: 10.1371/journal.pone.0226544. eCollection 2020.

4.

Deep Learning Analysis of Cerebral Blood Flow to Identify Cognitive Impairment and Frailty in Persons Living With HIV.

Luckett P, Paul RH, Navid J, Cooley SA, Wisch JK, Boerwinkle AH, Tomov D, Ances BM.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):496-502. doi: 10.1097/QAI.0000000000002181.

PMID:
31714429
5.

The Experiences of Homeless Youth When Using Strengths Profiling to Identify Their Character Strengths.

Cooley SJ, Quinton ML, Holland MJG, Parry BJ, Cumming J.

Front Psychol. 2019 Sep 24;10:2036. doi: 10.3389/fpsyg.2019.02036. eCollection 2019.

6.

Impact of Introduction of a Clinical Pathway for the Management of Pyelonephritis on Obstetric Patients: a Quality Improvement Project

Clooney L, Ronayne A, Glennon K, Brennan M, Hickey N, Magee C, Cooley S, Eogan M, Drew RJ.

Ir Med J. 2019 Jun 17;112(6):951.

PMID:
31538439
7.

Social inclusion and exclusion in same-race and interracial peer encounters.

Cooley S, Burkholder AR, Killen M.

Dev Psychol. 2019 Nov;55(11):2440-2450. doi: 10.1037/dev0000810. Epub 2019 Sep 19.

PMID:
31535895
8.

Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors.

Turan O, Bielecki P, Tong K, Covarrubias G, Moon T, Rahmy A, Cooley S, Park Y, Peiris PM, Ghaghada KB, Karathanasis E.

Mol Pharm. 2019 Oct 7;16(10):4352-4360. doi: 10.1021/acs.molpharmaceut.9b00693. Epub 2019 Sep 3.

PMID:
31442061
9.

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples.

Rashidi A, Luo X, Cooley S, Anasetti C, Waller EK, Brunstein CG, Cichocki F, Weisdorf DJ, Miller JS.

Blood Adv. 2019 Aug 27;3(16):2465-2469. doi: 10.1182/bloodadvances.2019000298. No abstract available.

10.

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

Cooley S, He F, Bachanova V, Vercellotti GM, DeFor TE, Curtsinger JM, Robertson P, Grzywacz B, Conlon KC, Waldmann TA, McKenna DH, Blazar BR, Weisdorf DJ, Miller JS.

Blood Adv. 2019 Jul 9;3(13):1970-1980. doi: 10.1182/bloodadvances.2018028332.

11.

Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.

O'Halloran JA, Cooley SA, Strain JF, Boerwinkle A, Paul R, Presti RM, Ances BM.

AIDS. 2019 Jul 15;33(9):1477-1483. doi: 10.1097/QAD.0000000000002236.

PMID:
31008801
12.

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Felices M, Kodal B, Hinderlie P, Kaminski MF, Cooley S, Weisdorf DJ, Vallera DA, Miller JS, Bachanova V.

Blood Adv. 2019 Mar 26;3(6):897-907. doi: 10.1182/bloodadvances.2018029371.

13.

Greenland Ice Sheet surface melt amplified by snowline migration and bare ice exposure.

Ryan JC, Smith LC, van As D, Cooley SW, Cooper MG, Pitcher LH, Hubbard A.

Sci Adv. 2019 Mar 6;5(3):eaav3738. doi: 10.1126/sciadv.aav3738. eCollection 2019 Mar.

14.

Adaptive NK cell reconstitution is associated with better clinical outcomes.

Cichocki F, Taras E, Chiuppesi F, Wagner JE, Blazar BR, Brunstein C, Luo X, Diamond DJ, Cooley S, Weisdorf DJ, Miller JS.

JCI Insight. 2019 Jan 24;4(2). pii: 125553. doi: 10.1172/jci.insight.125553. [Epub ahead of print]

15.

Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

Turcotte LM, Cao Q, Cooley SA, Curtsinger J, Holtan SG, Luo X, Yingst A, Weisdorf DJ, Blazar BR, Miller JS, Wagner JE, Verneris MR.

Biol Blood Marrow Transplant. 2019 May;25(5):883-890. doi: 10.1016/j.bbmt.2019.01.003. Epub 2019 Jan 6.

PMID:
30625388
16.

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

Bachanova V, Weisdorf DJ, Wang T, Marsh SGE, Cereb N, Haagenson MD, Spellman SR, Lee SJ, Guethlein LA, Parham P, Miller JS, Cooley SA.

Biol Blood Marrow Transplant. 2019 May;25(5):949-954. doi: 10.1016/j.bbmt.2018.12.763. Epub 2018 Dec 27.

PMID:
30594542
17.

Tau Positron Emission Tomography Binding Is Not Elevated in HIV-Infected Individuals.

Cooley SA, Strain JF, Beaumont H, Boerwinkle AH, Doyle J, Morris JC, Benzinger TL, Ances BM.

J Infect Dis. 2019 Jun 5;220(1):68-72. doi: 10.1093/infdis/jiy663.

PMID:
30561665
18.

Assessing regional drought impacts on vegetation and evapotranspiration: a case study in Guanacaste, Costa Rica.

Cooley SS, Williams CA, Fisher JB, Halverson GH, Perret J, Lee CM.

Ecol Appl. 2019 Mar;29(2):e01834. doi: 10.1002/eap.1834. Epub 2019 Jan 28.

PMID:
30536477
19.

Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.

Grzywacz B, Moench L, McKenna D Jr, Tessier KM, Bachanova V, Cooley S, Miller JS, Courville EL.

J Immunother. 2019 Feb/Mar;42(2):65-72. doi: 10.1097/CJI.0000000000000250.

20.

Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.

Lei L, Cooley SG, Phibbs CS, Kinosian B, Allman RM, Porsteinsson AP, Intrator O.

Health Serv Res. 2018 Dec;53 Suppl 3:5331-5351. doi: 10.1111/1475-6773.13048. Epub 2018 Sep 23.

21.

Projected impacts of future climate change, ocean acidification, and management on the US Atlantic sea scallop (Placopecten magellanicus) fishery.

Rheuban JE, Doney SC, Cooley SR, Hart DR.

PLoS One. 2018 Sep 21;13(9):e0203536. doi: 10.1371/journal.pone.0203536. eCollection 2018.

22.

KIR Donor Selection: Feasibility in Identifying better Donors.

Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson MD, Vierra-Green C, Spellman S, Spahn A, Vogel J, Kobusingye H, Fehninger T, Woolfrey A, Devine S, Ross M, Waller EK, Sobecks R, Parham P, Guethlein LA, Marsh SGE, Miller J; participating center writing committee.

Biol Blood Marrow Transplant. 2019 Jan;25(1):e28-e32. doi: 10.1016/j.bbmt.2018.08.022. Epub 2018 Aug 24.

23.

Interreader agreement of radiographic left atrial enlargement in dogs and comparison to echocardiographic left atrial assessment.

Duler L, LeBlanc NL, Cooley S, Nemanic S, Scollan KF.

J Vet Cardiol. 2018 Oct;20(5):319-329. doi: 10.1016/j.jvc.2018.07.004. Epub 2018 Aug 20.

PMID:
30139650
24.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

Warlick ED, DeFor TE, Bejanyan N, Holtan S, MacMillan M, Blazar BR, Dusenbery K, Arora M, Bachanova V, Cooley S, Lazaryan A, McGlave P, Miller JS, Rashidi A, Slungaard A, Vercellotti G, Ustun C, Brunsein C, Weisdorf D.

Biol Blood Marrow Transplant. 2019 Jan;25(1):56-62. doi: 10.1016/j.bbmt.2018.07.038. Epub 2018 Aug 1.

25.

Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells.

Yun HD, Felices M, Vallera DA, Hinderlie P, Cooley S, Arock M, Gotlib J, Ustun C, Miller JS.

Blood Adv. 2018 Jul 10;2(13):1580-1584. doi: 10.1182/bloodadvances.2018018176. No abstract available.

26.

Cognitive Performance and Frailty in Older HIV-Positive Adults.

Paul RH, Cooley SA, Garcia-Egan PM, Ances BM.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):375-380. doi: 10.1097/QAI.0000000000001790.

PMID:
29957675
27.

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.

Sarhan D, Brandt L, Felices M, Guldevall K, Lenvik T, Hinderlie P, Curtsinger J, Warlick E, Spellman SR, Blazar BR, Weisdorf DJ, Cooley S, Vallera DA, Önfelt B, Miller JS.

Blood Adv. 2018 Jun 26;2(12):1459-1469. doi: 10.1182/bloodadvances.2017012369.

28.

Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.

Sarhan D, Hippen KL, Lemire A, Hying S, Luo X, Lenvik T, Curtsinger J, Davis Z, Zhang B, Cooley S, Cichocki F, Blazar BR, Miller JS.

Cancer Immunol Res. 2018 Jul;6(7):766-775. doi: 10.1158/2326-6066.CIR-17-0498. Epub 2018 May 21.

29.

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

Bejanyan N, Brunstein CG, Cao Q, Lazaryan A, Luo X, Curtsinger J, Mehta RS, Warlick E, Cooley SA, Blazar BR, Miller JS, Weisdorf D, Wagner JE, Verneris MR.

Blood Adv. 2018 Apr 24;2(8):909-922. doi: 10.1182/bloodadvances.2017014464.

30.

A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.

Fehniger TA, Miller JS, Stuart RK, Cooley S, Salhotra A, Curtsinger J, Westervelt P, DiPersio JF, Hillman TM, Silver N, Szarek M, Gorelik L, Lowdell MW, Rowinsky E.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1581-1589. doi: 10.1016/j.bbmt.2018.03.019. Epub 2018 Mar 27.

31.

Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.

de Witte MA, Sarhan D, Davis Z, Felices M, Vallera DA, Hinderlie P, Curtsinger J, Cooley S, Wagner J, Kuball J, Miller JS.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1152-1162. doi: 10.1016/j.bbmt.2018.02.023. Epub 2018 Mar 2.

32.

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

Romee R, Cooley S, Berrien-Elliott MM, Westervelt P, Verneris MR, Wagner JE, Weisdorf DJ, Blazar BR, Ustun C, DeFor TE, Vivek S, Peck L, DiPersio JF, Cashen AF, Kyllo R, Musiek A, Schaffer A, Anadkat MJ, Rosman I, Miller D, Egan JO, Jeng EK, Rock A, Wong HC, Fehniger TA, Miller JS.

Blood. 2018 Jun 7;131(23):2515-2527. doi: 10.1182/blood-2017-12-823757. Epub 2018 Feb 20.

33.

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.

Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ.

Clin Cancer Res. 2018 Apr 15;24(8):1834-1844. doi: 10.1158/1078-0432.CCR-17-3196. Epub 2018 Feb 14.

34.

Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.

Cooley S, Parham P, Miller JS.

Blood. 2018 Mar 8;131(10):1053-1062. doi: 10.1182/blood-2017-08-752170. Epub 2018 Jan 22. Review.

35.

Early onset preeclampsia is associated with an elevated mean platelet volume (MPV) and a greater rise in MPV from time of booking compared with pregnant controls: results of the CAPE study.

Monteith C, Egan K, O'Connor H, Maguire P, Kevane B, Szklanna PB, Cooley S, Malone F, Áinle FN.

J Perinat Med. 2018 Nov 27;46(9):1010-1015. doi: 10.1515/jpm-2017-0188.

PMID:
29267172
36.

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells.

Bachanova V, Sarhan D, DeFor TE, Cooley S, Panoskaltsis-Mortari A, Blazar BR, Curtsinger JM, Burns L, Weisdorf DJ, Miller JS.

Cancer Immunol Immunother. 2018 Mar;67(3):483-494. doi: 10.1007/s00262-017-2100-1. Epub 2017 Dec 7.

37.

Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells.

Williams RL, Cooley S, Bachanova V, Blazar BR, Weisdorf DJ, Miller JS, Verneris MR.

Biol Blood Marrow Transplant. 2018 Mar;24(3):618-622. doi: 10.1016/j.bbmt.2017.11.022. Epub 2017 Nov 29.

38.

Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Bergerson RJ, Williams R, Wang H, Shanley R, Colbenson G, Kerber A, Cooley S, Curtsinger J, Felices M, Miller JS, Verneris MR.

Blood Adv. 2016 Dec 27;1(3):208-218. doi: 10.1182/bloodadvances.2016000158. Epub 2016 Oct 30.

39.

Transpalpebral ultrasonographic measurement of the optic nerve sheath diameter in healthy dogs.

Smith JJ, Fletcher DJ, Cooley SD, Thompson MS.

J Vet Emerg Crit Care (San Antonio). 2018 Jan;28(1):31-38. doi: 10.1111/vec.12677. Epub 2017 Nov 24.

PMID:
29171933
40.

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation.

Ustun C, Brunstein C, DeFor T, Rashidi A, Yohe S, Bejanyan N, Cooley S, Warlick E, Miller J, Linden MA, Weisdorf D.

Bone Marrow Transplant. 2018 Jan;53(1):97-100. doi: 10.1038/bmt.2017.212. Epub 2017 Oct 9. No abstract available.

PMID:
28991246
41.

Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant.

Tkachev V, Furlan SN, Watkins B, Hunt DJ, Zheng HB, Panoskaltsis-Mortari A, Betz K, Brown M, Schell JB, Zeleski K, Yu A, Kirby I, Cooley S, Miller JS, Blazar BR, Casson D, Bland-Ward P, Kean LS.

Sci Transl Med. 2017 Sep 20;9(408). pii: eaan3085. doi: 10.1126/scitranslmed.aan3085.

42.

Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

Paul R, Rhee G, Baker LM, Vaida F, Cooley SA, Ances BM.

J Neurovirol. 2017 Oct;23(5):725-733. doi: 10.1007/s13365-017-0557-5. Epub 2017 Sep 11.

43.

Thrombocalc: implementation and uptake of personalized postpartum venous thromboembolism risk assessment in a high-throughput obstetric environment.

O'Shaughnessy F, Donnelly JC, Cooley SM, Deering M, Raman A, Gannon G, Hickey J, Holland A, Hayes N, Bennett K, Ní Áinle F, Cleary BJ.

Acta Obstet Gynecol Scand. 2017 Nov;96(11):1382-1390. doi: 10.1111/aogs.13206. Epub 2017 Sep 21.

PMID:
28832906
44.

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Cichocki F, Valamehr B, Bjordahl R, Zhang B, Rezner B, Rogers P, Gaidarova S, Moreno S, Tuininga K, Dougherty P, McCullar V, Howard P, Sarhan D, Taras E, Schlums H, Abbot S, Shoemaker D, Bryceson YT, Blazar BR, Wolchko S, Cooley S, Miller JS.

Cancer Res. 2017 Oct 15;77(20):5664-5675. doi: 10.1158/0008-5472.CAN-17-0799. Epub 2017 Aug 8.

45.

Young children's inclusion decisions in moral and social-conventional group norm contexts.

Rizzo MT, Cooley S, Elenbaas L, Killen M.

J Exp Child Psychol. 2018 Jan;165:19-36. doi: 10.1016/j.jecp.2017.05.006. Epub 2017 Jun 20.

PMID:
28645542
46.

Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia.

Egan K, O'Connor H, Kevane B, Malone F, Lennon A, Al Zadjali A, Cooley S, Monteith C, Maguire P, Szklanna PB, Allen S, McCallion N, Ní Áinle F.

Thromb Haemost. 2017 Jul 26;117(8):1549-1557. doi: 10.1160/TH16-12-0949. Epub 2017 Jun 1.

PMID:
28569919
47.

Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.

Rashidi A, Ali AM, Vij KR, Shanley R, Romee R, Cooley SA, Westervelt P, DiPersio JF, Miller JS, Weisdorf DJ, Ustun C.

Am J Hematol. 2017 Sep;92(9):E549-E552. doi: 10.1002/ajh.24804. Epub 2017 Jul 19. Review. No abstract available.

48.

Measurement of Perceived Stress in Age-Related Macular Degeneration.

Dougherty BE, Cooley SL, Davidorf FH.

Optom Vis Sci. 2017 Mar;94(3):290-296. doi: 10.1097/OPX.0000000000001055.

49.

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia.

Ustun C, Williams S, Skendzel S, Kodal B, Arock M, Gotlib J, Vallera DA, Cooley S, Felices M, Weisdorf D, Miller J.

Am J Hematol. 2017 May;92(5):E66-E68. doi: 10.1002/ajh.24673. Epub 2017 Feb 24. No abstract available.

50.

Topological Organization of Whole-Brain White Matter in HIV Infection.

Baker LM, Cooley SA, Cabeen RP, Laidlaw DH, Joska JA, Hoare J, Stein DJ, Heaps-Woodruff JM, Salminen LE, Paul RH.

Brain Connect. 2017 Mar;7(2):115-122. doi: 10.1089/brain.2016.0457. Epub 2017 Feb 21.

Supplemental Content

Loading ...
Support Center